Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Peptide
BCAR1
Reactivity: Human
Host: Synthetic
BP, BI
-
- Target See all BCAR1 products
- BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- BCAR1 peptide corresponds to 13 amino acids of BCAR1.
-
-
- Application Notes
- BCAR1 peptide is used for blocking the activity of BCAR1 antibody . The BCAR1 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- BCAR1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))
- Gene ID
- 9564
- NCBI Accession
- NP_001164185, NP_001164186, NP_001164187, NP_001164188, NP_001164189, NP_055382, NP_001164190, NP_001164191, NP_001164192
- OMIM
- 44662836
- UniProt
- P56945
-
You are here:
